Create account

Coverage dated November 10, 2026

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

Headline from STAT

Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. STAT

    STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug (opens STAT)

    Published

    STAT's feed description

    Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

  2. The Boston Globe

    Dutch antitrust regulators probe Biogen over test for its MS drug (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    Stories you may have missed from the world of business.

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug | Since Then